We are live on
!
Find out more
BCM
Bayesian Capital Management Portfolio holdings
AUM
$81.9M
1-Year Est. Return
26.59%
This Fund
S&P 500
This Quarter
Est. Return
-1.32%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$493M
AUM Growth
-$43.7M
(-8.1%)
Cap. Flow
-$6.65M
Cap. Flow
% of AUM
-1.35%
Top 10 Holdings %
Top 10 Hldgs %
14.21%
Holding
1,115
New
370
Increased
135
Reduced
155
Closed
453
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$15.8M |
| 2 |
Micron Technology
MU
|
+$9.79M |
| 3 |
Medtronic
MDT
|
+$7.24M |
| 4 |
Meta Platforms (Facebook)
META
|
+$6.64M |
| 5 |
Alibaba
BABA
|
+$5.41M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Truist Financial
TFC
|
+$6.76M |
| 2 |
Qualcomm
QCOM
|
+$6.11M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$4.04M |
| 4 |
EOG Resources
EOG
|
+$4.02M |
| 5 |
T-Mobile US
TMUS
|
+$3.82M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.08% |
| 2 | Healthcare | 13.66% |
| 3 | Consumer Discretionary | 12.3% |
| 4 | Industrials | 9.83% |
| 5 | Financials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VISN
426
Vistance Networks Inc
VISN
$2.67B
| $286K | 0.06% |
+31,100
| New | +$298K |
|
427
Equifax
EFX
$20.8B
| $286K | 0.06% |
+1,666
| New | +$326K |
|
428
Medpace
MEDP
$16.5B
| $286K | 0.06% |
1,820
-3,500
| -66% | -$559K |
|
429
IonQ
IONQ
$13.4B
| $285K | 0.06% |
56,300
-11,400
| -17% | -$63.2K |
|
430
Macerich
MAC
$7.41B
| $284K | 0.06% |
35,800
-33,100
| -48% | -$321K |
|
431
BWX Technologies
BWXT
$16.2B
| $282K | 0.06% |
+5,592
| New | +$302K |
|
432
Yum! Brands
YUM
$40.7B
| $282K | 0.06% |
+2,651
| New | +$308K |
|
433
Popular Inc
BPOP
$10.9B
| $281K | 0.06% |
+3,900
| New | +$303K |
|
434
Huntsman Corp
HUN
$2.06B
| $281K | 0.06% |
11,470
+1,699
| +17% | +$47.8K |
|
435
Globus Medical
GMED
$10.6B
| $280K | 0.06% |
+4,700
| New | +$283K |
|
436
Sun Life Financial
SLF
$46B
| $279K | 0.06% |
7,024
+1,800
| +34% | +$80.7K |
|
|
PCH
437
DELISTED
PotlatchDeltic
PCH
| $275K | 0.06% |
+6,700
| New | +$308K |
|
|
HCP
438
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $274K | 0.06% |
+8,500
| New | +$293K |
|
439
Avnet
AVT
$7.25B
| $272K | 0.06% |
7,541
-5,200
| -41% | -$224K |
|
440
Fomento Económico Mexicano
FMX
$45B
| $272K | 0.06% |
4,341
-400
| -8% | -$25.2K |
|
|
KNBE
441
DELISTED
KnowBe4, Inc. Class A Common Stock
KNBE
| $272K | 0.06% |
13,091
-2,500
| -16% | -$46.1K |
|
|
DAWN
442
DELISTED
Day One Biopharmaceuticals
DAWN
| $271K | 0.05% |
+13,508
| New | +$287K |
|
443
Lemonade
LMND
$4.76B
| $271K | 0.05% |
+12,811
| New | +$291K |
|
444
Qiagen
QGEN
$8.47B
| $271K | 0.05% |
6,186
+1,413
| +30% | +$69.8K |
|
445
Equity Residential
EQR
$25.2B
| $270K | 0.05% |
4,016
-22,200
| -85% | -$1.64M |
|
446
Gildan
GIL
$9.38B
| $269K | 0.05% |
+9,525
| New | +$284K |
|
447
ASML
ASML
$636B
| $268K | 0.05% |
+645
| New | +$323K |
|
448
Celanese
CE
$4.87B
| $267K | 0.05% |
2,950
-2,150
| -42% | -$236K |
|
449
Oshkosh
OSK
$9.66B
| $267K | 0.05% |
+3,794
| New | +$309K |
|
|
SAGE
450
DELISTED
Sage Therapeutics
SAGE
| $266K | 0.05% |
+6,800
| New | +$263K |
|
Similar funds
KL
FWS
FRIHG
AGFVA
1C
MP
FLC
APW
Bayesian Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Bayesian Capital Management held 1,115 positions worth $493M, down 8.1% from $537M the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Bayesian Capital Management's Q3 2022 filing shows 370 new, 135 increased, 155 reduced and 453 closed positions. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 39,700 shares worth $14.2M. The largest sale was Truist Financial, an estimated $6.76M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Bayesian Capital Management's largest Q3 2022 buy was State Street SPDR S&P 500 ETF Trust: 39,700 shares worth $14.2M.
- Bayesian Capital Management added most to Medtronic in Q3 2022, an estimated $7.24M increase.
- Bayesian Capital Management's biggest Q3 2022 reduction was Truist Financial, cutting an estimated $6.76M.
- Bayesian Capital Management fully exited Walgreens Boots Alliance in Q3 2022, selling an estimated $4.04M.
- Bayesian Capital Management's ten largest holdings make up 14% of its $493M portfolio in Q3 2022.
- Bayesian Capital Management opened 370 new positions and closed 453 in Q3 2022.
- Bayesian Capital Management's portfolio value fell 8.1% quarter-over-quarter to $493M.
Based on Bayesian Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.